Refine by
Industries served
- Medical / Health Care
- Agriculture
- Energy
- Monitoring and Testing
- Water and Wastewater
- Chemical & Pharmaceuticals
- Environmental
- Health and Safety
- Manufacturing, Other
- Electronics and Computers
- Aerospace & Air Transport
- Metal
- Air and Climate
- Plastics & Resins
- Waste and Recycling
- Oil, Gas & Refineries
- University / Academia / Research
- Mining
- Automobile & Ground Transport
- Banking & Finance / Insurance / Legal
- Defense
- Paint
- Communications / Telecom / Datacom
- Food and Beverage
- Construction & Construction Materials
- Furniture
- Dry Cleaning
- Domestic
- Forestry & Wood
- Glassware
- Packaging
- Commercial
- Logistics
- Leather & Tanning
- Printing
- Textile
- Soil and Groundwater
- Government
Medical Industry Technology Serving Austria
313 companies found
Technologybased inAtlanta, GEORGIA (US) (USA)
Hypercell has developed a proprietary point-of-care diagnostic technology platform that is as accurate as the gold standard PCR, 10x faster, and without expensive lab equipment. Hypercell allows the detection of biological contaminants in the food ...
Hypercell Allows Stakeholders Along The Entire Food Chain To Rapidly Identify, Manage And Respond To Biological ...
Technologybased inWichita, KANSAS (USA)
Neotherma Oncology is led by experienced healthcare executives who are working toward the dream of more effective treatments for cancer. NeoTherma Oncology is developing a groundbreaking type of radio frequency (RF) thermal treatment for deep solid ...
Technologybased inYongin-si, SOUTH KOREA
Vivozon is a global innovative drug development company established in 2008. We built an efficacy-based new drug discovery system that is clearly distinct from the existing new drug development paradigm, and discovered the non- narcotic analgesic ...
Opiranserin (VVZ-149) for injection is a first-in-class non-narcotic analgesic under development by Vivozon. As atreatment for postoperative pain used as a first-line therapy in the global market, Opiranserin aims to ultimately replaceopioid ...
Technologybased inEindhoven, NETHERLANDS
Our work builds on decades of research and translational science by giants in this important and emerging field. We were formed in 2014 by researchers at the Swiss Federal Institute of Technology (EPFL). We are now headquartered at the High Tech ...
Technologybased inAustin, TEXAS (USA)
Natera is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard of care to protect health and inform earlier, more ...
Renasight is a test to determine if there is a genetic cause for an individual’s kidney disease or if there is an increased hereditary risk due to family history. The test uses a blood or saliva sample to test 385 genes associated with chronic ...
Technologybased inCambridge, UNITED KINGDOM
Based in Cambridge, one of Europe's largest bioscience hubs, Biorbyt has a simple yet challenging mission: to provide the best service to the global scientific community. We achieve this by collaborating with the world’s finest researchers and ...
Plasma cells are specialised B lymphocytes that secrete antibodies (glycoproteins) in response to infection by antigens (toxins or foreign substances). Antibodies, also known as immunoglobulins (Ig), usually have a high affinity to a specific ...
Technologybased inNew York, NEW YORK (USA)
Stemline Therapeutics is a commercial-stage biopharmaceutical company focused on the development and commercialization of novel oncology therapeutics. The goal of our dedicated team of scientists, specialists, researchers, and developers is to build ...
ELZONRISTM (tagraxofusp, SL-401) — ELZONRIS is a novel targeted therapy directed to the interleukin-3 (IL-3) receptor-α (CD123), a target present on a wide range of malignancies. ELZONRIS was approved by the US Food and Drug ...
Technologybased inVerona, ITALY
At Sibylla Biotech, we face the complexity of drug discovery with the power of an innovative approach for meeting unmet medical needs. Born out of a scientific challenge, the PPI-FIT protocol (Pharmacological Protein Inactivation by Folding ...
We are currently working on the hit-to-lead process for KRAS and Cyclin D1 (CCND1) proteins in the biology ...
Technologybased inWoburn, MASSACHUSETTS (USA)
Founded in 2007, HUABIO is dedicated to developing curated, high-quality antibodies that advance innovation. We're passionate about the accuracy, efficiency, and consistency of our products. We devote our company mission to the disruption of an ...
Western blot analysis of GARS on Raji cell lysates. Proteins were transferred to a PVDF membrane and blocked with 5% BSA in PBS for 1 hour at room temperature. The primary antibody (ET1610-67, 1/500) was used in 5% BSA at room temperature for 2 ...
Technologybased inTaipei, City, TAIWAN
Bened Biomedical Co., Ltd. was founded in 2015 in Taipei, Taiwan. One of its founders, Professor Ying-Chieh Tsai (National Yang-Ming University), has spent decades studying fermentation and probiotics. It was in his lab where Bened’s first ...
Lactiplantibacillus plantarum PS128: 12+ clinical studies. Probiotic Product of the Year Winner (2018 & 2021 NutraIngredients-Asia Awards). 60 million+ doses sold. Safe to use (GRAS, QPS). Vegan (isolated from mustard greens). Kosher and ...
Technologybased inBengaluru, INDIA
Kalmane Tech specialises in developing cutting edge products and technologies for all kinds of automation applications - including designing custom embedded hardware and firmware. The numerous projects that we have implemented for our customers ...
Technologybased inAmes, ALABAMA (USA)
Mazen Animal Health harnesses the power of plant biotechnology to create orally delivered biologics, aimed at significantly improving animal health and welfare. The company's innovative cross-species platform is versatile enough to target various ...
The Oralogics™ Technology Platform from Mazen Animal Health revolutionizes animal vaccination through molecular farming, enabling vaccines to be administered via feed instead of traditional injections. This pioneering approach enhances animal ...
Technologybased inMelbourne, AUSTRALIA
Starpharma Holdings Limited is a global biopharmaceutical company and a world leader in the development of new pharmaceutical and medical products based on proprietary polymers called dendrimers, with programs for COVID-19, DEP drug delivery and ...
DEP® irinotecan is an improved version of irinotecan (Camptosar®), predominantly used for colorectal cancer. DEP® irinotecan is a novel, patented nanoparticle formulation of SN-38, the active metabolite of irinotecan, delivered using ...
Technologybased inPoway, CALIFORNIA (USA)
VetStem Biopharma has endeavored to improve the lives of animals through regenerative medicine. As the first company in the United States to provide an adipose-derived stem cell service to veterinarians for their patients, VetStem pioneered the use ...
VetStem Regenerative Cells – Key Safety Factors: Autologous (from the patient back to the same patient): Tissue reaction risk is minimized. Minimally manipulated: Cells are not differentiated or modified. Accurate determination of each dose. ...
Technologybased inSaint Paul, MINNESOTA (USA)
Innovation Focused on Improving Patient Care: Manufactured from our pharmaceutical grade of NOCC chitosan polymer technology, the PosiSep® X hemostat dressing/intranasal splint provides both superior performance and patient comfort. There is really ...
Different Platforms for Your Individual Needs. NexPak®X Intranasal Splint is intended to prevent adhesions in the nasal and sinus cavity after surgery or trauma while minimizing bleeding and edema. NexPak®X Intranasal Splint is indicated ...
Technologybased inExeter, UNITED KINGDOM
Attomarker is a British company focused on nanophotonic biochemical testing. It was founded in 2008, and spun out from Professor Andrew Shaw’s research group at the University of Exeter. It has won numerous prestigious awards for innovation and been ...
Technologybased inBoston, MASSACHUSETTS (USA)
Neoclease is at the forefront of advancing gene editing technologies with a mission to transform healthcare by curing genetic diseases rather than just treating them. Utilizing a bespoke approach, the company develops tailored nucleases designed to ...
Neoclease is pioneering the future of precision medicine through advanced technology in synthetic biology and generative AI. By developing synthetic nucleases, the company enhances gene editing processes to achieve unprecedented specificity and ...
Technologybased inBundoora, AUSTRALIA
AdAlta is an innovative, clinical stage biotech company developing a unique range of new drug treatments. AdAlta has pioneered a technology that mimics the shape and stability of a crucial antigen-binding domain, discovered initially in sharks and ...
AdAlta and Carina Biotech to develop next-generation i-body enabled CAR-T cancer therapeutics. AdAlta has entered a collaboration agreement with Carina Biotech to develop next-generation i-body enabled CAR-T cells, with the potential to bring CAR-T ...
Technologybased inWest Jordan, UTAH (USA)
AMD LASERS is the world’s leading dental laser company and dental technology innovator. For over a decade AMD has been providing ultra-affordable laser technology for dental professionals prepared to take their practice to the next level. Our goal ...
The Picasso Lite+ Diode Laser was designed for versatility, usability, precision, and affordability. Offering a wide range of necessary capabilities for soft tissue surgical procedures and periodontal treatments, the Picasso Lite+ soft ...
Technologybased inCambridge, UNITED KINGDOM
GW is the global leader in developing cannabinoid-based medicines. GW has been researching cannabinoids since 1998 and has established a world leading position in the development of plant-derived cannabinoid therapeutics. GW has established a world ...
Many of the childhood-onset intractable epilepsy conditions within the expanded access program share considerable overlap with ASD and these conditions often fall within the orphan disease space. Initial clinical observations from treating ...